Physician profile

Errol C Anderson

Vascular & Interventional Radiology · Odessa, TX

NPI 1932101680

$2,970.24

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

See the full distribution for Vascular & Interventional Radiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$301.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic Vascular, INC. $2,171.35 2019
Terumo Medical Corporation $330.05 2019-2020
Siemens Medical Solutions USA, INC. $282.99 2021-2023 Somatom Force, Magnetom Skyra, Artis Zee Ceiling
Penumbra, INC. $112.04 2023 Indigo System
Medtronic USA, INC. $55.08 2019-2020
Medtronic, INC. $18.73 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Errol C Anderson

$2,970.24

in general payments reported 2019-2025

Years
2019-2023
Top company
Medtronic Vascular, INC.

https://glasscript.com/doctor/446805/errol-c-anderson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.